Kangfude Bio Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
90
- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
5
Kangfude Bio General Information
Description
Developer of oral enzyme and microecological drugs designed for the treatment of metabolic diseases. The company utilizes recombinant protein expression in filamentous fungi, enzyme glycosylation, and bioinformatics-guided engineering to produce oxalate decarboxylase TRA16 and microecological treatments, enabling healthcare providers to manage urinary calculi, hyperoxalemia, and gout through targeted oral therapies.
Contact Information
Website
www.kfdbio.comCorporate Office
- Building B06, Optics Valley Biomedical Park
- Wuhan, Hubei 430075
- China
Corporate Office
- Building B06, Optics Valley Biomedical Park
- Wuhan, Hubei 430075
- China
Kangfude Bio Timeline
Kangfude Bio Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Kangfude Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Kangfude Bio Patents
Kangfude Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026209044-A1 | Urate oxidase mutant and use thereof | Pending | 03-Apr-2025 | ||
| WO-2024183792-A1 | Protein with no or low methionine content and use thereof | Inactive | 09-Mar-2023 | ||
| WO-2019169855-A1 | Recombinant oxalate decarboxylase expressed by filamentous fungi host cells | Inactive | 07-Mar-2017 | ||
| US-11613745-B2 | Recombinant oxalate decarboxylase expressed in filamentous fungi | Active | 07-Mar-2017 | ||
| US-20210002625-A1 | Recombinant oxalate decarboxylase expressed in filamentous fungi | Active | 07-Mar-2017 | C12N9/88 |
Kangfude Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Kangfude Bio Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Kangfude Bio FAQs
-
When was Kangfude Bio founded?
Kangfude Bio was founded in 2010.
-
Where is Kangfude Bio headquartered?
Kangfude Bio is headquartered in Wuhan, China.
-
What is the size of Kangfude Bio?
Kangfude Bio has 90 total employees.
-
What industry is Kangfude Bio in?
Kangfude Bio’s primary industry is Drug Discovery.
-
Is Kangfude Bio a private or public company?
Kangfude Bio is a Private company.
-
What is Kangfude Bio’s current revenue?
The current revenue for Kangfude Bio is .
-
How much funding has Kangfude Bio raised over time?
Kangfude Bio has raised $9.2M.
-
Who are Kangfude Bio’s investors?
Wuhan Hanyang Investment Development Group, Wuhan Yunzhong Private Equity Fund Management, Huatai-PineBridge Fund Management, JT Asset Management, and Mingdao Investment are 5 of 7 investors who have invested in Kangfude Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
